High prevalence of infection with hepatitis B and C viruses in patients with hepatocellular carcinoma in Japan

Hepato-Gastroenterology

Volumn 46, Issue 25, 1999, Pages 357-359

  Kubo, Shoji ^a   Nishiguchi, Shuhei ^a   Hirohashi, Kazuhiro ^a   Tanaka, Hiromu ^a   Tsukamoto, Tadashi ^a   Hamba, Hiroyuki ^a   Shuto, Taichi ^a   Okuda, Toyokazu ^a   Tamori, Akihiro ^a   Kuroki, Tetsuo ^a   Kinoshita, Hiroaki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS RNA;

ARTICLE; HEPATITIS B; HEPATITIS C; HUMAN; JAPAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SERODIAGNOSIS;

CARCINOMA, HEPATOCELLULAR; HEPACIVIRUS; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; JAPAN; LIVER NEOPLASMS; PREVALENCE; RNA, VIRAL;

EID: 0033000325     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. 1 Suga M, Senota K, Arima K, Kodama T, Ikuta S, Sakamoto H, Ohe Y, Sugai Y, Yachi A: Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma. Hepato-Gastroenterol 1994; 41:438-441.
2. 2 Kubo S, Nishiguchi S, Kuroki T, Hirohashi K, Tanaka H, Tsukamoto T, Shuto T, Kinoshita H: Poor association of GBV C viremia with hepatocellular carcinoma. J Hepatol 1997; 27:91-95.
3. 3 Hasan F, Jeffers LJ, DeMedina M, et al: Hepatitis C-associated hepatocellular carcinoma. Hepatol 1990; 12:589-591.
4. 4 Ruiz J, Sangro B, Cuende JI, Beloqui O, Riezu-Boj J, Herrero JI, Prieto J: Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatol 1992; 16:637-641.
5. 5 Hwang S-J, Tong MJ, Lai PP, Ko ES, Co RL, Chien D, Kuo G: Evaluation of hepatitis B and C viral markers: clinical significance in the United States of America. J Gastroenterol Hepatol 1996; 11:949-954.
6. 6 Peterlini P, Gerken G, Nakajima E, Terre S, D'Errico A, Grigioni W, Nalpas B, Franco D, Wands J, Kew M, Tiollais PP, Brechot C: Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990; 323:80-85.
7. 7 Liang TJ, Jeffers LJ, Reddy KR, De Medina M, Parker IT, Cheinquer H, Idrovo V, Rabassa A, Schiff ER; Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatol 1993; 18:1326-1333.
8. 8 Peterlini P, Poussin K, Kew M, Franco D, Brechot C: Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatol 1995; 21:313-321.
9. 9 Fujiyama A, Miyanohara A, Nozaki C, Yoneyama T, Ohtomo N, Matsubara K: Cloning and structural analyses of hepatitis B virus DNAs, subtype. Nucleic Acids Res 1983; 11:4601-4610.
10. 10 Kew MC, Hougton M, Choo QL, Kuo G: Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet 1990; 335:873-874.
11. 11 Bruix JJM, Barrera X, Calvet G, Ercilla J, Costa JM, Sanchez Tapias M, Ventura M, et al: Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; ii:1004-1006.
12. 12 Colombo MG, Kuo QL, Choo MF, Donato E, Del Ninno MA, Tommasini N, Dioguardi M, Houghton M: Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; ii:1006-1008.
13. 13 Yu MC, Tong MJ, Coursaget P, Ross RK, Govindarajan A, Henderson BE: Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 1990; 82:1038-1041.
14. 14 Kubo S, Nishiguchi S, Tamori A, Hirohashi K, Kinoshita H, Kuroki T: Development of hepatocellular carcinoma in patients with hepatitis C virus infection and with or without past hepatitis B virus infection, and relationship to age at blood transfusion. Vox Sang, (in press)
15. 15 Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, Kumada H, Kawanishi M: A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatol 1993; 18:47-53.
16. 16 Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, Shiomi S, Seki S, Kobayashi K, Otani S: Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995; 346:1051-1055.
17. 17 Bruno S, Silini E, Crosignani A, Borzio F, Leandro G, Bono F, Asti M, Rossi S, Larghi A, Cerino A, Podda M, Mondelli MU: Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatol 1997; 25:754-758.